Tyr-Somatostatin-14,58100-03-1, Peptide synthesis

Dirction：Tyr-Somatostatin-14 (GT-P1731, CAS 58100-03-1) is a synthetic peptide with a disulfide bridge between Cys4 and Cys15. Its formula is C₈₅H₁₁₃N₁₉O₂₁S₂ and MW 1801.09. Manufactured via solid-phase peptide synthesis, it is supplied for endocrine and somatostatin receptor related academic research with reliable purity.

basic information:

brand: solid extension

appearance traits : white powder

storage: shading , cool drying , sealed preservation purity: ≥ 99% main use : Polypeptide Research Use

execution standard: enterprise standard

specifications: mg/g/kg, etc ( subject to customer requirements )

sales Scope: Global

peptide frequently asked questions:

1. How to judge whether the quality of peptide synthesis is qualified?

Each polypeptide will come: -HPLC chromatogram (purity test) -MS (Molecular Weight Verification) after the customer receives it, it can be verified again in combination with the experimental requirements, and can be retested and confirmed if necessary.

2. What modifications are supported? Does the modification affect the cycle?

Supporting modifications include, but are not limited: -Fluorescent labeling (FITC, Cy5, etc.) -Cyclization, phosphorylation, fatty acid -Biotinylation, C- terminal amidation, N-terminal acetylation, etc. Complex modification will appropriately extend the synthesis cycle, generally 7 to 12 working days, it is recommended to evaluate in advance.